Article
FDA Seeks To Accelerate Biosimilar Development By Easing Data Requirements
The U.S. Food and Drug Administration (FDA) significantly revised its approach to biosimilar drug development on October 29. Specifically, FDA issued a draft guidance recommending...
Wiley Rein